Search

everythinglearnresearchcommunity

for

Search:↓

Canadian porcupines in a Japanese zoo passed a skin fungus to each other.

Key genes linked to hair growth and cancer were identified in hairless mice.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

HSPGs help control stem cell behavior, affecting hair growth and offering a target for hair loss treatments.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Melatonin helps hair growth in women with hair loss.

To manage hair loss in adult women, find the cause and treat it accordingly.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

The article explains how to tell apart and treat two common causes of hair loss in women.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Low vitamin D3 levels are significantly linked to hair loss, especially in female students.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.